What We Do
Optoacoustic intubation improves accuracy and speed while placing endotracheal tubes in patients. Decision-assist software helps clinicians intubate patients safe and faster.
The Product
[PROTOTYPE] PoET – noninvasive, optoacoustic device that determines precisely where an endotracheal tube is located within the trachea.
Target Customer Pain Points
- While the majority of endotracheal tubes (ET) are placed successfully, care teams encounter difficult patients and need additional support.
- Pediatric and Adult Intensive Care Physicians, EM Physicians no longer wait to confirm ET position and can expedite ET cuff malfunction
- Respiratory therapists no longer wait to confirm ET position
- Emergency Medical Technicians no longer wait to confirm ET position
- Transport teams can maintain continuous certainty of ET position
Differentiation
- Dramatically reduces volume of chest radiographs (including associated exposure to radiation) to assess tube position
- Reduces the incidence of unrecognized right mainstem intubation and associated atelectasis
- Reduces the incidence of accidental extubation
Market Size
Current market size of tracheal intubation is estimated at $3 billion annually, with 13% of the procedures defined as difficult due to known complications.
Progress & Milestones
- Developed and tested prototype for device as well as software to clinically-assist the clinician
- Clinical prototype requires only 15 to 30 seconds and does not require interruption of mechanical ventilation or movement of a patient
- Designed razorblade business model to create early incentives for adoption with a long tail of revenue opportunity
- Conduct clinical trials for FDA clearance as well as secure CE mark
Management Team
- Donald Prough, MD
- Yuriy Petrov, PhD
- Graham Randall, PhD, MBA
- Tommy Cooper
Download this document